Articles tagged "Kidney transplantation"

2021 American Transplant Congress
Kidney Transplantation in Patients with Prior Coronavirus Disease 2019 (COVID-19)
A. Santeusanio, A. Bhansali, M. Rana, S. Lerner, D. Von Ahrens, O. Sulimani, S. Farouk, F. Tedla, R. Shapiro
Mount Sinai Hospital, New York, NY
*Purpose: We describe short-term outcomes as well as peri- and post-transplant complications in patients with prior coronavirus disease 2019 (COVID-19) who subsequently underwent kidney transplantation.*Methods:…
2021 American Transplant Congress
Allocating Kidneys in Optimized Circles: Logistics are More Important Than Distance
R. Saidi, R. Shahbazov, M. Hanlon, M. laftavi
SUNY Upstate, Syracuse, NY
*Purpose: The OPTN recently proposed removing Donation Service Area (DSA) and regional boundaries used in the current kidney allocation system (KAS) and allocate organs within…
2021 American Transplant Congress
Correlation of Coronary Anatomy and Interventions with Post-kidney Transplantation Outcomes
A. Sharma, T. Teigeler, D. Kumar, S. Moldowan, C. Bhati, G. Gupta, L. Kang, M. Levy
Virginia Commonwealth University, Richmond, VA
*Purpose: There is considerable variation in the preoperative coronary evaluation before kidney transplantation (KT) and subsequent reporting of outcomes.*Methods: Patients who received a KT (from…
2021 American Transplant Congress
Covid-19 Related Deaths Across the U.S. in Kidney Transplant Recipients
K. Goli, N. T. Galvan, R. Cotton, J. A. Goss, C. A. O'Mahony, A. Rana
Department of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: The COVID-19 pandemic poses a unique challenge for immunosuppression patients following kidney transplantation. Studies involving a single center or few centers have suggested that…
2021 American Transplant Congress
Desensitization Using Clazakizumab® (anti-il-6) in Highly-hla Sensitized Patients Awaiting Kidney Transplant (nct03380962)
A. A. Vo¹, N. Ammerman¹, E. Huang¹, M. Toyoda², S. Ge², A. Peng¹, R. Najjar¹, S. Sethi¹, S. Williamson¹, C. Myers¹, K. Lim¹, M. Gillespie¹, S. Jordan¹
¹Kidney Transplant, Cedars Sinai Medical Ctr, Los Angeles, CA, ²Transplant Immunology Laboratory, Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: IL-6 is a critical cytokine for plasma cell IgG production. Clazakizumab (CSL Behring LLC) is a humanized monoclonal aimed at the cytokine IL-6. Here…
2021 American Transplant Congress
Response to a Pandemic: The Fall and Rise of Kidney Transplantation in the US
S. Bisen¹, B. Boyarsky¹, W. Werbel¹, J. Snyder², J. Garonzik-Wang¹, D. Segev¹, A. Massie¹
¹JHU, Baltimore, MD, ²SRTR, Minneapolis, MN
*Purpose: During the first wave of the COVID-19 epidemic in March-April 2020, waitlist registrations and living/deceased donor kidney transplants (LDKT/DDKT) dropped substantially. A second wave…
2021 American Transplant Congress
Inflammation in Scarred Cortex (i-IFTA) is Significantly Associated with T Cell-mediated Rejection (TCMR), but Not Antibody-mediated Rejection (ABMR), in Renal Allograft Biopsies (Bx)
H. Zhang
Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: I-IFTA in renal allograft Bx has been found to be associated with decreased death-censored graft survival. Moderate to severe i-IFTA (2 or 3) is…
2021 American Transplant Congress
Extracellular Matrix Injury of Kidney Allografts in Antibody-mediated Rejection
S. Clotet Freixas¹, C. McEvoy¹, I. Batruch², C. Pastrello³, M. Kotlyar³, J. Van¹, M. Arambewela¹, A. Boshart¹, S. Farkona¹, Y. Niu³, Y. Li¹, O. Famure¹, A. Bozovic⁴, V. Kulasingam⁴, P. Chen¹, J. S. Kim¹, E. Chan⁵, S. Moshkelgosha¹, S. A. Rahman⁶, J. Das⁶, T. Martinu¹, S. Juvet¹, I. Jurisica³, A. Chruscinski¹, R. John¹, A. Konvalinka¹
¹Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, ²Department of Laboratory Medicine and Pathobiology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada, ³Krembil Research Institute, University Health Network, Toronto, ON, Canada, ⁴Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada, ⁵Department of Medicine, Division of Nephrology, University Health Network, Toronto, ON, Canada, ⁶Center for Systems Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
*Purpose: Antibody-mediated rejection (AMR) accounts for >50% of kidney graft losses. AMR is caused by donor-specific antibodies (DSA) against HLA and non-HLA antigens in glomeruli…
2021 American Transplant Congress
Journey to Transplant: A Pilot Feasibility Trial of a Virtual Counseling Intervention for Patients and Their Social Support Networks to Improve Access to Kidney Transplant
A. Hart¹, R. Edpuganti², H. D'Cunha², S. Kurschner², W. T. McKinney¹, A. Matas¹, R. Patzer¹, S. Chu¹, M. Bruin¹, M. Partin¹
¹Hennepin Healthcare, University of Minnesota, Minneaplis, MN, ²Hennepin Healthcare Research Institute, Minneaplis, MN
*Purpose: Home counseling interventions have shown promise in increasing rates of kidney transplant, but are challenging to implement. We piloted a structured but individualized virtual…
2021 American Transplant Congress
Primary Uretero-ureterostomy in Renal Transplantation
H. Shokouh-Amiri¹, M. S. Naseer¹, D. Aultman¹, R. McMillan¹, S. Tandukar², F. T. Siskron³, N. Singh², G. Zibari¹
¹Advanced Surgery, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, ²Transplant Nephrology, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, ³Urology, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA
*Purpose: Uretero-neocystostomy (UN) is routinely performed in renal transplantation. Few studies of primary uretero-ureterostomy (UU) have been reported, showing its safety and feasibility. If the…